르 라보레또레 쎄르비에르;LES LABORATOIRES SERVIER;VERNALIS (R&D) LTD.;베르날리스 (알 앤드 디) 리미티드
发明人:
LE TIRAN ARNAUD,르 티랑, 아누,LE DIGUARHER THIERRY,르 디구아르허, 띠에리,STARCK JEROME BENOIT,스탁, 제롬-베누,HENLIN JEAN MICHEL,헨린, 장-미셸,GUILLOUZIC ANNE FRANCOISE,기유지, 안느-프랑수아,DE NANTEUIL GUILLAUME,드 낭퇴유, 기욤,GENESTE OLI,LE TIRAN ARNAUDFR,LE DIGUARHER THIERRYFR,STARCK JEROME BENOITFR,HENLIN JEAN MICHELFR,GUILLOUZIC ANNE FRANCOISEFR,DE NANTEUIL GUILLAUMEFR
申请号：
KR1020160178093
公开号：
KR1020170001695A
申请日:
2016.12.23
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to new pyrrole compounds and a process for preparation thereof and pharmaceutical compositions containing the same. More specifically, the present invention relates to the compounds of chemical formula 1, enantiomers, diastereomers, or pharmaceutically permitted additional salt with acids or bases. In addition to novelty, the present invention has apoptosis-inducing properties which make the compounds available in pathology including apoptosis defects. The compounds and medicines in the chemical formula 1: A1, A2, Ra, Rb, Rc, Rd, R3, R4, R5 and T in the formula 1 are as defined in detailed description.하기 화학식 (I)의 화합물과 의약:상기 식에서, A1, A2, Ra, Rb, Rc, Rd, R3, R4, R5 및 T는 상세한 설명에서 정의된 바와 같다.
